Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Hikma Pharmaceuticals Reaches Licensing Agreement With Celltrion

Dec 19 (Reuters) - Hikma Pharmaceuticals: 
    * REACHES LICENSING AGREEMENT WITH CELLTRION FOR THIRD 
BIOSIMILAR 
PRODUCT IN MIDDLE EAST AND NORTH AFRICA 
    * LICENSING AGREEMENT FOR BIOSIMILAR MONOCLONAL ANTIBODY 
(MAB) IN 
ONCOLOGY TO BE GRANTED EUROPEAN MARKETING AUTHORISATION, 
TRUXIMA 
 
Source text for Eikon:  ID:nRSS6681Za  
Further company coverage:  068270.KQ  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news